Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease
W. E. Boertien, E. Meijer, D. Zittema, M. A. van Dijk, T. J. Rabelink, M. H. Breuning, J. Struck, S. J. L. Bakker, D. J. M. Peters, P. E. de Jong, R. T. Gansevoort
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf.
W. E. Boertien, E. Meijer, D. Zittema, M. A. van Dijk, T. J. Rabelink, M. H. Breuning, J. Struck, S. J. L. Bakker, D. J. M. Peters, P. E. de Jong, R. T. Gansevoort. "Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease." Nephrology, Dialysis and Transplantation 27.11 (2012) 4131-4137